The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Ketamine Alleviates Depressive-Like Behaviors via Down-Regulating Inflammatory Cytokines Induced by Chronic Restraint Stress in Mice
Open accessAbstract
The purpose of the present study was to investigate whether ketamine's rapid antidepressant effects were associated with its anti-inflammatory actions and to explore the underlying molecular mechanism. Depressive-like behaviors was induced in mice using chronic restraint stress (CRS) method. Anti-depressive effects of ketamine were evaluated by forced swimming tests (FST) and sucrose preference test (SPT). Subsequently, brain tissue was harvested to investigate inflammatory response in the hippocampus via investigating reactive microglia numbers, serum cytokines levels and the toll-like receptor type 4 (TLR4)/p38 mitogen-activated protein kinase (MAPK) pathway. CRS exposure caused depressive-like behaviors in mice, which was associated with increased pre-inflammatory cytokines (interleukin (IL)-1β, tumor necrosis factor (TNF)-α and IL-6) levels, reactive microglia numbers and up-regulated regulatory molecules such as TLR4/p38 and P2X7 receptor in hippocampus. Such neurobehavioral and biochemical abnormalities were normalized by ketamine treatment. CRS-induced depression-like behaviours are associated with activation of hippocampal inflammatory response, whereas down-regulation of pro-inflammatory cytokines may contribute to ketamine's antidepressant effects in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the antidepressant-like effect induced by clemasine [80] and ketamine [81] were associated with decreased hippocampal P2X7R levels in the in stressed mice.”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [81]
In the citing paper
“and exposure of mice to chronic restraint stress (CRS) increased hippocampal P2X7R levels [81].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993
Regulation of the Hypothalamic‐Pituitary‐Adrenocortical Stress Response
Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Makinson, R., Scheimann, J., & Myers, B. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c150015 · Cited by 1,819
Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
Zarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811
Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791
Chiba, S., Numakawa, T., Ninomiya, M., Richards, M. C., Wakabayashi, C., & Kunugi, H. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.018 · Cited by 673
Cited by
Sorted by citations
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Wang, H., He, Y., Sun, Z., Ren, S., Liu, M., Wang, G., & Yang, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02492-0 · Cited by 605
Neurobiology of Resilience: Interface Between Mind and Body
Cathomas, F., Murrough, J. W., Nestler, E. J., Han, M.-H., & Russo, S. J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.011 · Cited by 296
Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment
He, X., Gao, Y., Ng, D., Michalopoulou, E., George, S., Adrover, J. M., Sun, L., Albrengues, J., Daßler‐Plenker, J., Han, X., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.01.013 · Cited by 311
Microglia in depression: current perspectives
Jia, X., Gao, Z., & Hu, H. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1815-6 · Cited by 288
Chen, M.-H., Li, C.-T., Lin, W.-C., Hong, C.-J., Tu, P.-C., Bai, Y.-M., Cheng, C.-M., & Su, T.-P. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.078 · Cited by 159
The P2X7 Receptor: Central Hub of Brain Diseases
Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162
Nowak, W., Grendas, L. N., Sanmarco, L. M., Estecho, I. G., Arena, Á. R., Eberhardt, N., Rodante, D. E., Aoki, M. P., Daray, F. M., Carrera Silva, E. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.063 · Cited by 159
Donoso, F., Cryan, J. F., Olavarría‐Ramírez, L., Nolan, Y. M., & Clarke, G. A. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2581 · Cited by 155
Getachew, B., Aubee, J. I., Schottenfeld, R. S., Csoka, A. B., Thompson, K. M., & Tizabi, Y. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1373-7 · Cited by 140
Neuroinflammation: The central enabler of postoperative cognitive dysfunction
Liu, Y., Yang, W., Xue, J., Chen, J., Liu, S., Zhang, S., Zhang, X., Gu, X., Dong, Y., & Qiu, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115582 · Cited by 139
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129
The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis
Mi, W., Xia, Y., & Bian, Y. (2019) · Inflammation Research · doi:10.1007/s00011-019-01220-4 · Cited by 129
Recent advances in CNS P2X7 physiology and pharmacology: Focus on neuropsychiatric disorders
Bhattacharya, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00030 · Cited by 115
Inflaming sex differences in mood disorders
Rainville, J. R., & Hodes, G. E. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0124-7 · Cited by 112
van Vuren, E. J., Steyn, S. F., Brink, C. B., Möller, M., Viljoen, F. P., & Harvey, B. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111200 · Cited by 106
Brain region–specific action of ketamine as a rapid antidepressant
Chen, M., Ma, S., Liu, H., Dong, Y., Tang, J., Ni, Z., Tan, Y. J., Duan, C.-C., Li, H., Huang, H., et al. (2024) · Science · doi:10.1126/science.ado7010 · Cited by 105
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Kopra, E. I., Mondelli, V., Pariante, C. M., & Nikkheslat, N. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211026426 · Cited by 106
Serna-Rodríguez, M. F., Bernal‐Vega, S., de la Barquera, J. A. O.-S., Camacho‐Morales, A., & Pérez‐Maya, A. A. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577951 · Cited by 105
Mohammadi, A. B., Torbati, M., Farajdokht, F., Sadigh‐Eteghad, S., Fazljou, S. M. B., Vatandoust, S. M., Golzari, S. E., & Mahmoudi, J. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.020 · Cited by 91
Farooq, R. K., Tanti, A., Ainouche, S., Roger, S., Belzung, C., & Camus, V. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.016 · Cited by 83
Bhattacharya, A., Lord, B., Grigoleit, J., He, Y., Fraser, I. C., Campbell, S. N., Taylor, N., Aluisio, L. E., O’Connor, J. C., Papp, M., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0141-6 · Cited by 84
Zhan, Y., Zhou, Y., Zheng, W., Liu, W., Wang, C., Lan, X., Deng, X., Xu, Y., Zhang, B., & Ning, Y. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00933-z · Cited by 81
Namba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76
Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
Illés, P., Verkhratsky, A., & Tang, Y. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00331 · Cited by 78
Medeiros, G. C., Gould, T. D., Prueitt, W. L., Nanavati, J., Grunebaum, M. F., Farber, N. B., Singh, B., Selvaraj, S., Machado-Vieira, R., Achtyes, E. D., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01652-1 · Cited by 75
Fu, S., Wang, J., Hao, C., Dang, H., & Jiang, S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05210-6 · Cited by 74
Nikkheslat, N. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100383 · Cited by 72
Xie, L., Gu, Z., Liu, H., Jia, B., Wang, Y., Cao, M., Song, R., Zhang, Z., & Bian, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01251 · Cited by 70
Li, J., Liu, L.-L., Su, W., Wang, B., Zhang, T., Zhang, Y., & Jiang, C. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.022 · Cited by 68
Wen, Y., Xu, J., Shen, J., Tang, Z., Li, S., Zhang, Q., Li, J., & Sun, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03860-4 · Cited by 71
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Johnston, J. N., Greenwald, M. S., Henter, I. D., Kraus, C., Mkrtchian, A., Clark, N. G., Park, L. T., Gold, P. W., Zarate, C. A., & Kadriu, B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103518 · Cited by 68
Flux, M. C., & Lowry, C. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104578 · Cited by 70
Guo, Y., Xie, J., Li, X., Yuan, Y., Zhang, L., Hu, W., Luo, H., Yu, H., & Zhang, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01126 · Cited by 64
An update on NMDA antagonists in depression
Pochwat, B., Nowak, G., & Szewczyk, B. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1643237 · Cited by 67
Duan, C., Zhang, J., Wan, T.-F., Wang, Y., Chen, D., & Liu, L. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112296 · Cited by 66
Han, Q.-Q., Huang, H., Wang, Y., Liu, Y., Pilot, A., Zhu, X., Yu, R., Wang, J., Chen, X., Liu, Q., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.013 · Cited by 53
Stress, pain, anxiety, and depression in endometriosis–Targeting glial activation and inflammation
Mokhtari, T., Irandoost, E., & Sheikhbahaei, F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111942 · Cited by 59
Mechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage
Wu, Y., Wang, L., Hu, K., Yu, C., Zhu, Y., Zhang, S., & Shao, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00682 · Cited by 49
Gürsel (2018) · doi:10.1016/j.neubiorev.2018.02.005 · Cited by 47
Sun, Y., Yan, T.-X., Gong, G.-W., Li, Y., Zhang, J., Wu, B., Bi, K.-S., & Jia, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107029 · Cited by 51
Cathomas, F., Bevilacqua, L., Ramakrishnan, A., Kronman, H., Costi, S., Schneider, M., Chan, K. L., Li, L., Nestler, E. J., Shen, L., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-021-01712-0 · Cited by 47
The effects of anaesthetics and sedatives on brain inflammation
Dominguini, D., Steckert, A. V., Michels, M., Borges, M. S., Ritter, C., Barichello, T., Thompson, J. P., & Dal‐Pizzol, F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.009 · Cited by 44
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
Sharma, S., & Akundi, R. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302120322 · Cited by 44
Neurobiological biomarkers of response to ketamine
Kadriu, B., Ballard, E. D., Henter, I. D., Murata, S., Gerlus, N., & Zarate, C. A. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.05.003 · Cited by 36
Guo, Y., Xie, J., Zhang, L., Yang, L., Ma, J., Bai, Y., Ma, W., Wang, X., Yu, H., Zeng, Y.-Q., et al. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135561 · Cited by 36
Immunoregulation and antidepressant effect of ketamine
Zhang, N., Yao, L., Wang, P., & Liu, Z. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0167 · Cited by 35
Serum miR-221-3p as a new potential biomarker for depressed mood in perioperative patients
Feng, J., Wang, M., Li, M., Yang, J., Jia, J., Liu, L., Zhou, J. F., Zhang, C., & Wang, X. (2019) · Brain Research · doi:10.1016/j.brainres.2019.06.015 · Cited by 34
Ketamine – A New Antidepressant Drug with Anti-Inflammatory Properties
Jóźwiak-Bębenista, M., Sokołowska, P., Wiktorowska‐Owczarek, A., Kowalczyk, E., & Sienkiewicz, M. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001823 · Cited by 33
Ma, W., Li, L., & Xing, S. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146335 · Cited by 32
Mograbi, K. D. M., Suchecki, D., da Silva, S. G., Covolan, L., & Hamani, C. (2020) · Stress · doi:10.1080/10253890.2020.1712355 · Cited by 35
Dong, Y., Wang, X., Zhou, Y., Zheng, Q., Chen, Z., Zhang, H., Sun, Z., Xu, G., & Hu, G. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104741 · Cited by 32
Brain immune cells characterization in UCMS exposed P2X7 knock-out mouse
Troubat, R., Leman, S., Pinchaud, K., Surget, A., Barone, P. R., Roger, S., Guisquet, A. L., Brizard, B., Belzung, C., & Camus, V. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.02.012 · Cited by 34
Frinchi, M., Nuzzo, D., Scaduto, P., Carlo, M. D., Massenti, M. F., Belluardo, N., & Mudò, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-50708-w · Cited by 31
A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics?
Eltokhi, A., & Sommer, I. E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.852506 · Cited by 32
Zhou, Y., Wu, F., Wang, C., Zheng, W., Lan, X., Deng, X., & Ning, Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.068 · Cited by 28
NLRP1-Mediated Antidepressant Effect of Ketamine in Chronic Unpredictable Mild Stress Model in Rats
Arıcıoğlu, F., Yalçınkaya, C., Özkartal, C. Ş., Tüzün, E., Şirvancı, S., Küçükali, C. İ., & Utkan, T. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0189 · Cited by 27
Ketamine as a prophylactic resilience-enhancing agent
Evers, A. G., Murrough, J. W., Charney, D. S., & Costi, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.833259 · Cited by 28
Recent Advances in the Mechanisms of Postoperative Neurocognitive Dysfunction: A Narrative Review
Wang, T., Huang, X., Sun, S., Wang, Y., Han, L., Zhang, T., Zhang, T., & Chen, X. (2025) · Biomedicines · doi:10.3390/biomedicines13010115 · Cited by 27
Li, P., Zhang, F., Li, Y., Zhang, C., Yang, Z., Zhang, Y., & Song, C. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211032473 · Cited by 28
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
Gil, B., Smith, J., Tang, Y., Illés, P., & Engel, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042380 · Cited by 27
Ketamine: A Neglected Therapy for Alzheimer Disease
Smalheiser, N. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00186 · Cited by 30
Zhao, J., Zhang, R., Wang, W., Jiang, S., Liang, H., Guo, C., Qi, J., Zeng, H., & Song, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109880 · Cited by 25
VanderZwaag, J., Halvorson, T., Dolhan, K., Šimončičová, E., Ben‐Azu, B., & Tremblay, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03772-0 · Cited by 28
Astroglial Mechanisms of Ketamine Action Include Reduced Mobility of Kir4.1-Carrying Vesicles
Stenovec, M., Božić, M., Pirnat, S., & Zorec, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02744-1 · Cited by 25
Chen, H., Ma, Y., Chen, M., Chen, J., & Jin, C. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1728 · Cited by 24
Purinergic P2X7 receptor as a potential therapeutic target in depression
Wang, Q., Jin, X., & Guan, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115959 · Cited by 22
Smiley, C. E., & Wood, S. K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108212 · Cited by 24
P2X7 Receptor as a Potential Target for Major Depressive Disorder
Huang, Z., & Tan, S. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141908 · Cited by 20
Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSD
Wellington, N. J., Bouças, A. P., Lagopoulos, J., Quigley, B. L., & Kuballa, A. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06756-4 · Cited by 21
Tan, Q., He, L.-Y., He, Z., Liu, W., Zhang, S., Lin, L., Yang, H., & Guan, L. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-021-02742-5 · Cited by 19
Li, T., Huang, Z., Wang, X., Zou, J., & Tan, S. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0003 · Cited by 19
Peng, F., Fan, J., Ge, T., Liu, Q. Q., & Li, B. J. (2020) · Cell Proliferation · doi:10.1111/cpr.12804 · Cited by 19
Kalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18
Fekri, K., Nayebi, A. M., Sadigh‐Eteghad, S., Farajdokht, F., & Mahmoudi, J. (2020) · Neurochemical Journal · doi:10.1134/s181971242002004x · Cited by 19
Gagne, C., Piot, A., & Brake, W. G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.797577 · Cited by 18
Reflections on the neuroscientific legacy of Jaak Panksepp (1943–2017)
Watt, D. F. (2017) · Neuropsychoanalysis · doi:10.1080/15294145.2017.1376549 · Cited by 18
He, M., Feng, R., Wang, J., Xia, S., Wang, Y., & Zhang, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.950143 · Cited by 17
Murck, H., Lehr, L., & Ježová, D. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13219 · Cited by 16
Cao, Y., Chen, H. L., Tan, Y., Yu, X., Xiao, C., Li, Y. Q., Reilly, J., He, Z., & Shu, X. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114415 · Cited by 17
Yu, Y., He, X., Wang, Y., Zhang, J., Tang, C., & Rong, P. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136562 · Cited by 16
Kristóf, Z., Eszlári, N., Sütöri, S., Gál, Z., Török, D., Baksa, D., Petschner, P., Sperlágh, B., Anderson, I. M., Deakin, J. F. W., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252766 · Cited by 16
Misztak, P., Sowa-Kućma, M., Pańczyszyn-Trzewik, P., Szewczyk, B., & Nowak, G. (2021) · Molecules · doi:10.3390/molecules27010022 · Cited by 17
Han, W., Zheng, Y., Wang, L., & An, C. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578172 · Cited by 17
Effect of General Anesthetic Agents on Microglia
Yang, Y., Hang, W., Li, J., Liu, T., Hu, Y., Fang, F., Yan, D., McQuillan, P. M., Wang, M., & Hu, Z. (2023) · Aging and Disease · doi:10.14336/ad.2023.1108 · Cited by 15
Kang, M. J. Y., & Vázquez, G. H. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.047 · Cited by 13
Hao, Y., Niu, H., An, S., Wang, M., & Wang, Z. (2018) · Journal of Immunology Research · doi:10.1155/2018/3256908 · Cited by 14
Scott, K. A., Phan, T., Boukelmoune, N., Heijnen, C. J., & Dantzer, R. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.017 · Cited by 13
Wu, G.-H., Guo, Q.-H., Xu, X., Lin, J.-C., You, G.-T., Lin, C., & Zhang, L.-C. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01236-0 · Cited by 12
Magnesium and ketamine in the treatment of depression.
Górska, N., Słupski, J., Szałach, Ł. P., Włodarczyk, A., Szarmach, J., Jakuszkowiak‐Wojten, K., Gałuszko‐Węgielnik, M., Wilkowska, A., Wiglusz, M. S., & Cubała, W. J. (2019) · PubMed · Cited by 12
Wang, Y., Yang, Q., Chen, C., Yao, Y., Yuan, X., & Zhang, K. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01913-w · Cited by 11
Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
Kositsyn, Y. M., de Abreu, M. S., Kolesnikova, T. O., Lagunin, A. A., Poroikov, V., Harutyunyan, H. S., Yenkoyan, K. B., & Kalueff, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119482 · Cited by 11
Edem, E. E., Anyanwu, C.-K. C., Nebo, K. E., Akinluyi, E. T., Fafure, A. A., Ishola, A. O., & Enye, L. A. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06021-4 · Cited by 9
Flowers, J. C., Vetter, P. E., Wiles, M. J., Roh, S. H., Black, E. R., Bouckova, E., Wustrau, M. H., Lee, R., Lee, S.-H., & Kim, S. (2025) · The FASEB Journal · doi:10.1096/fj.202501763r · Cited by 11
Chronic restraint stress alters rat behavior depending on sex and duration of stress
Pansarim, V., Leite‐Panissi, C. R. A., & Schmidt, A. (2023) · Behavioural Processes · doi:10.1016/j.beproc.2023.104856 · Cited by 9
Nouri, M., Farajdokht, F., Torbati, M., Ranjbar, F., Hamedyazdan, S., Sadigh‐Eteghad, S., & Araj‐Khodaei, M. (2019) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.95438 · Cited by 9
Rice bran supplement ameliorates chronic restraint stress-induced depression-like behaviors in mice
Kim, M., Yoon, M., Cho, S., Kim, M. J., & Um, M. Y. (2024) · Food & Function · doi:10.1039/d4fo00718b · Cited by 8
Lamontagne, S. J., Ballard, E. D., & Zarate, C. A. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100450 · Cited by 10
Wenhui, Z., Li, W., Jiang, J., Wang, D., Mao, X., Zhang, J., Zhang, X., Chang, J., Yao, P., Yang, X., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1071327 · Cited by 8
Serotonergic neurons in the treatment of mood disorders: The dialogue with astrocytes
Charvériat, M., & Guiard, B. P. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.006 · Cited by 7
Involvement of proBDNF in Monocytes/Macrophages with Gastrointestinal Disorders in Depressive Mice
Yu, Y.-Q., Zhang, Y., Wang, Z., Liu, Y., Li, H., Zhou, X., Hu, Z., & Dai, R. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00235-8 · Cited by 6
Metadata
- Authors
- Tan, S., Wang, Y., Chen, K., Long, Z., & Zou, J.
- Affiliations
- University of South China (CN)
- Venue
- Biological & Pharmaceutical Bulletin
- Publisher
- Pharmaceutical Society of Japan
- Published
- 2017
- Volume
- 40
- Issue
- 8
- Pages
- 1260-1267
- ISSN
- 0918-6158 (ISSN-L)
- 1347-5215
- OpenAlex
- W2741144353
- Cited by
- 142
- References
- 42
- Citations by year
- 2026: 3 · 2025: 16 · 2024: 10 · 2023: 19 · 2022: 23 · 2021: 19 · 2020: 19 · 2019: 20 · 2018: 12 · 2017: 1
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Biological and Pharmaceutical Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of South China
- Construct Program of the Key Discipline in Hunan Province
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- ketamine, rapid antidepressant effects, chronic restraint stress, depression-like behavior, neuroinflammation, hippocampus, microglial activation, inflammatory cytokines, P2X7 receptor, IL-1β, TNF-α, interleukin-6, antidepressant mechanism
- MeSH terms
- Animals, Antidepressive Agents, Behavior, Animal, Corticosterone, Food Preferences, Hippocampus, Ketamine, Restraint, Physical, Stress, Psychological, Sucrose, Swimming, Down-Regulation, Cytokines, Excitatory Amino Acid Antagonists, p38 Mitogen-Activated Protein Kinases, Toll-Like Receptor 4, Mice, Receptors, Purinergic P2X7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review